Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine

Table 2

Alloantibody specificity and frequency in 116 Palestinian SCD patients.

Alloantibody specificity	Frequency and percentage of alloantibody, n (%)
Anti-K	3 (33.3%)
Anti-E	2 (22.2%)
Anti-D	1 (11.1%)
Anti-C	1 (11.1%)
Anti-c	1 (11.1%)
Anti-D, -C	1 (11.1%)
Total	9 (100%)